Education
About Us
Working with TipRanks
Follow Us
GoodRx Holdings (GDRX)
NASDAQ:GDRX
GDRX Stock Chart & Stats
$3.66
-$0.12(-2.72%)
At close: 4:00 PM EST
$3.66
-$0.12(-2.72%)
Day’s Range― - ―
52-Week Range$3.31 - $6.52
Previous CloseN/A
Volume261.88K
Average Volume (3M)5.03M
Market Cap
$1.27B
Enterprise Value$2.04B
Total Cash (Recent Filing)$281.32M
Total Debt (Recent Filing)$547.54M
Price to Earnings (P/E)39.4
Beta0.87
Next Earnings
Nov 04, 2025EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.09
Shares Outstanding98,580,670
10 Day Avg. Volume3,153,262
30 Day Avg. Volume5,025,359
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)2.48
Price to Sales (P/S)2.26
P/FCF Ratio15.80
Enterprise Value/Market Cap1.61
Enterprise Value/Revenue2.56
Enterprise Value/Gross Profit2.80
Enterprise Value/Ebitda11.48
Forecast
1Y Price Target
$5.29Price Target Upside44.54% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Bulls Say, Bears Say
Bulls Say
Government CollaborationGDRX traded materially higher on heavy volume following news that the company could potentially partner with TrumpRx.
PartnershipsGoodRx expands partnership with Kroger to offer branded drugs at a discounted price through RxSmartSaver, available in 2,200 pharmacies across 35 states.
Product OfferingGoodRx announced a collaboration with Novo Nordisk to offer Ozempic and Wegovy on the GoodRx platform for $499 per month.
Bears Say
CompetitionSignificant competition in direct-to-consumer offerings like hair loss, sexual health, and weight loss could become a challenge for GDRX.
Financial GuidanceManagement lowered its 2025 guide due to further RAD store closures and lower ISP contribution.
Pharmacy ClosuresHeadwinds from pharmacy closures and an evolving PBM-to-pharmacy reimbursement environment contribute to maintaining the Underperform rating on GDRX.
GoodRx Holdings News
GDRX FAQ
What was GoodRx Holdings’s price range in the past 12 months?
GoodRx Holdings lowest stock price was $3.31 and its highest was $6.52 in the past 12 months.
What is GoodRx Holdings’s market cap?
GoodRx Holdings’s market cap is $1.27B.
When is GoodRx Holdings’s upcoming earnings report date?
GoodRx Holdings’s upcoming earnings report date is Nov 04, 2025 which is in 5 days.
How were GoodRx Holdings’s earnings last quarter?
GoodRx Holdings released its earnings results on Aug 06, 2025. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.099 by -$0.009.
Is GoodRx Holdings overvalued?
According to Wall Street analysts GoodRx Holdings’s price is currently Undervalued.
Does GoodRx Holdings pay dividends?
GoodRx Holdings does not currently pay dividends.
What is GoodRx Holdings’s EPS estimate?
GoodRx Holdings’s EPS estimate is 0.09.
How many shares outstanding does GoodRx Holdings have?
GoodRx Holdings has 98,580,670 shares outstanding.
What happened to GoodRx Holdings’s price movement after its last earnings report?
GoodRx Holdings reported an EPS of $0.09 in its last earnings report, missing expectations of $0.099. Following the earnings report the stock price went down -20.046%.
Which hedge fund is a major shareholder of GoodRx Holdings?
Currently, no hedge funds are holding shares in GDRX
GoodRx Holdings Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.29 (44.54% Upside)
$5.29 (44.54% Upside)
Blogger Sentiment
Bullish
GDRX Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 40.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $159.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 12.8%
Last 30 Days ▲ 12.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-42.36%
12-Months-Change
Fundamentals
Return on Equity
5.27%
Trailing 12-Months
Asset Growth
-10.62%
Trailing 12-Months
Company Description
GoodRx Holdings
GoodRx Holdings, Inc. is a healthcare technology company that operates in the digital health sector, primarily focused on providing prescription drug price transparency and savings solutions. Through its platform, GoodRx enables consumers to compare prices for medications at various pharmacies, access coupons, and find discounts, ultimately aiming to make healthcare more affordable. The company's core products include its website and mobile applications that offer price comparisons, telehealth services, and pharmacy discount cards, catering to a wide range of consumers seeking to lower their prescription drug costs.
GDRX Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong performance in the Pharma Manufacturer Solutions segment and improvements in adjusted EBITDA margins. However, significant challenges from the Rite Aid bankruptcy and ISP volume declines negatively impacted revenue. While there are promising initiatives and partnerships underway, the immediate financial outlook faces headwinds.View all GDRX earnings summariesGDRX Revenue Breakdown
73.41% Prescription transactions
12.58% Subscription
11.34% Pharma manufacturer solutions
2.67% Other
GDRX Stock 12 Month Forecast
Average Price Target
$5.29
▲(44.54% Upside)
Technical Analysis
Ownership Overview
6.91% Insiders
12.94% Mutual Funds
0.26% Other Institutional Investors
68.46% Public Companies and Individual Investors